Aderan 16Mg Tablet
Aderan 16 mg Tablet (Candesartan ARB)
- Contains Candesartan 16 mg for effective daily hypertension control.
- Relaxes blood vessels to lower blood pressure and reduce cardiovascular risk.
- Once-daily dosing offers simplicity and consistency for patients.
Details
Aderan 16 mg Tablet
Aderan 16 mg Tablet contains Candesartan cilexetil 16 mg, a commonly used angiotensin II receptor blocker (ARB) for hypertension and selected heart failure cases. It helps open up blood vessels to reduce blood pressure and cardiovascular stress.
Forms / Strengths
Tablets: 4 mg, 8 mg, 16 mg, 32 mg
16 mg is a mid-range strength commonly used for initial or maintenance therapy
Main Uses (with localized benefits)
Management of hypertension in adults
Adjunct therapy in heart failure (with reduced ejection fraction)
Helps reduce risks of stroke, heart attack, and kidney damage in hypertensive patients
Usage Instructions
Take 1 tablet once daily, at the same time each day.
May be taken with or without food.
Do not skip doses; continue even if feeling well.
Your doctor may adjust the dose (often to 32 mg) depending on response.
Regular monitoring of blood pressure, renal function, and electrolytes is advised.
Side Effects
Dizziness, lightheadedness (especially on initial dosing)
Back pain, respiratory infections
Hyperkalemia (elevated potassium), renal impairment in predisposed individuals
Interactions
Potassium supplements, potassium-sparing diuretics (risk of high potassium)
NSAIDs may reduce antihypertensive effect and impair kidney function
Aliskiren combination contraindicated in diabetics or renal disease
Warnings / Precautions (with localized warnings)
Avoid during pregnancy (2nd/3rd trimester) due to fetal toxicity.
Use caution in patients with volume depletion or salt restriction.
Monitor renal function and potassium periodically.
Store below ~25-30 °C, protect from moisture.
Use with caution in settings where lab monitoring is limited.
Quick Product Facts Table

Mechanism of Action
Candesartan binds to angiotensin II type-1 (AT1) receptors in vascular smooth muscle, blocking the actions of angiotensin II (a potent vasoconstrictor). This leads to vasodilation, lower aldosterone release, decreased sodium and water retention, and ultimately reduced blood pressure.
Reviews
There are no reviews yet